Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abida Raza

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Bioorganic Chemistry|November 18, 2025
UHPLC-based phytochemical profiling and network pharmacology insights into mint-derived selenium nanoparticlesTayyaba Yousaf, Ilyas Ahmad, Naveed Iqbal Raja, et al.
Chinese Medical Journal|July 12, 2011
Predictors of response to antiviral therapy in patients with chronic hepatitis C from Pakistani populationHafsa Aziz, Muhammad Amin Athar, Shahnaz Murtaza, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapyHafsa Aziz, Abida Raza, Khawar Ali, et al.
Nanomaterials (Basel, Switzerland)|July 9, 2022
Glycol-Chitosan-Based Technetium-99m-Loaded Multifunctional Nanomicelles: Synthesis, Evaluation, and In Vivo BiodistributionNashmia Zia, Zafar Iqbal, Abida Raza, et al.
Scientific Reports|June 13, 2018
Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapyAyesha Obaid, Anam Naz, Aqsa Ikram, et al.
International Journal of Pharmaceutics|March 20, 2018
Fabrication of poly (butadiene-block-ethylene oxide) based amphiphilic polymersomes: An approach for improved oral pharmacokinetics of SorafenibMuhammad Adeeb Khan, Shaukat Ali, Subbu S Venkatraman, et al.
Current Pharmaceutical Biotechnology|October 2, 2019
Synergistic Antibacterial Efficacy of Biogenic Synthesized Silver Nanoparticles using Ajuga bractosa with Standard Antibiotics: A Study Against Bacterial PathogensSadia Nazer, Saiqa Andleeb, Shaukat Ali, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 15, 2011
Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in PakistanHafsa Aziz, Muzaffar Latif Gil, Yasir Waheed, et al.
Photodiagnosis and Photodynamic Therapy|January 25, 2022
In-vitro co-delivery of decarbazine and photosense using poly lactic-co-glycolic acid nanocarrier for combinational therapyMaryam Arshad, Ishrat Mahjabeen, Abida Raza, et al.
International Journal of Nanomedicine|June 9, 2021
Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR <i>Acinetobacter baumannii</i>: In silico, in vitro and in vivo StudiesAfreenish Hassan, Aamer Ikram, Abida Raza, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Bioorganic Chemistry|November 18, 2025
UHPLC-based phytochemical profiling and network pharmacology insights into mint-derived selenium nanoparticlesTayyaba Yousaf, Ilyas Ahmad, Naveed Iqbal Raja, et al.
Chinese Medical Journal|July 12, 2011
Predictors of response to antiviral therapy in patients with chronic hepatitis C from Pakistani populationHafsa Aziz, Muhammad Amin Athar, Shahnaz Murtaza, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapyHafsa Aziz, Abida Raza, Khawar Ali, et al.
Nanomaterials (Basel, Switzerland)|July 9, 2022
Glycol-Chitosan-Based Technetium-99m-Loaded Multifunctional Nanomicelles: Synthesis, Evaluation, and In Vivo BiodistributionNashmia Zia, Zafar Iqbal, Abida Raza, et al.
Scientific Reports|June 13, 2018
Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapyAyesha Obaid, Anam Naz, Aqsa Ikram, et al.
International Journal of Pharmaceutics|March 20, 2018
Fabrication of poly (butadiene-block-ethylene oxide) based amphiphilic polymersomes: An approach for improved oral pharmacokinetics of SorafenibMuhammad Adeeb Khan, Shaukat Ali, Subbu S Venkatraman, et al.
Current Pharmaceutical Biotechnology|October 2, 2019
Synergistic Antibacterial Efficacy of Biogenic Synthesized Silver Nanoparticles using Ajuga bractosa with Standard Antibiotics: A Study Against Bacterial PathogensSadia Nazer, Saiqa Andleeb, Shaukat Ali, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 15, 2011
Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in PakistanHafsa Aziz, Muzaffar Latif Gil, Yasir Waheed, et al.
Photodiagnosis and Photodynamic Therapy|January 25, 2022
In-vitro co-delivery of decarbazine and photosense using poly lactic-co-glycolic acid nanocarrier for combinational therapyMaryam Arshad, Ishrat Mahjabeen, Abida Raza, et al.
International Journal of Nanomedicine|June 9, 2021
Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR <i>Acinetobacter baumannii</i>: In silico, in vitro and in vivo StudiesAfreenish Hassan, Aamer Ikram, Abida Raza, et al.
Pageof 6